Substituted chiral allosteric hemoglobin modifiers
US6894185B2 · kind B2 · utility
2Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 2002 |
| Grant date | May 17, 2005 |
| Priority date | — |
| Expiry date | Dec 26, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A family of substituted chiral allosteric effectors of hemoglobin is useful for delivering more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.